Literature DB >> 34913349

Endocrine risk factors for COVID-19 in context of aging.

L Máčová1, M Bičíková, R Hampl.   

Abstract

Aged people are the most susceptible group to COVID-19 infection. Immunosenescence characterized by impairment of immune function with inflamm-aging contributes to pathophysiological alterations, among which endocrine and metabolic diseases are not exception. Diabetes, obesity along with impairment of disorders of thyroid functions are the most frequent ones, the common feature of which is failure of immune system including autoimmune processes. In the minireview we discussed how COVID-19 and aging impact innate and adaptive immunity, diabetes and selected neuroendocrine processes. Mentioned is also beneficial effect of vitamin D for attenuation of these diseases and related epigenetic issues. Particular attention is devoted to the role of ACE2 protein in the light of its intimate link with renin-angiotensin regulating system.

Entities:  

Mesh:

Year:  2021        PMID: 34913349      PMCID: PMC8884371          DOI: 10.33549/physiolres.934723

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  43 in total

Review 1.  Epigenetic mechanisms regulating COVID-19 infection.

Authors:  Sarantis Chlamydas; Athanasios G Papavassiliou; Christina Piperi
Journal:  Epigenetics       Date:  2020-07-30       Impact factor: 4.528

2.  1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

Authors:  Weihua Yuan; Wei Pan; Juan Kong; Wei Zheng; Frances L Szeto; Kari E Wong; Ronald Cohen; Anna Klopot; Zhongyi Zhang; Yan Chun Li
Journal:  J Biol Chem       Date:  2007-08-09       Impact factor: 5.157

Review 3.  COVID-19 and the immune system.

Authors:  J Paces; Z Strizova; D Smrz; J Cerny
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

Review 4.  Diabetes, infection risk and COVID-19.

Authors:  Suheda Erener
Journal:  Mol Metab       Date:  2020-06-23       Impact factor: 7.422

5.  Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.

Authors:  Amr H Sawalha; Ming Zhao; Patrick Coit; Qianjin Lu
Journal:  Clin Immunol       Date:  2020-04-08       Impact factor: 3.969

Review 6.  Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters.

Authors:  Keiji Kuba; Yumiko Imai; Takayo Ohto-Nakanishi; Josef M Penninger
Journal:  Pharmacol Ther       Date:  2010-07-03       Impact factor: 12.310

7.  Opposing activities of IFITM proteins in SARS-CoV-2 infection.

Authors:  Guoli Shi; Adam D Kenney; Elena Kudryashova; Ashley Zani; Lizhi Zhang; Kin Kui Lai; Luanne Hall-Stoodley; Richard T Robinson; Dmitri S Kudryashov; Alex A Compton; Jacob S Yount
Journal:  EMBO J       Date:  2020-12-21       Impact factor: 11.598

Review 8.  Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review.

Authors:  Zahra Raisi-Estabragh; Adrian R Martineau; Elizabeth M Curtis; Rebecca J Moon; Andrea Darling; Susan Lanham-New; Kate A Ward; Cyrus Cooper; Patricia B Munroe; Steffen E Petersen; Nicholas C Harvey
Journal:  Aging Clin Exp Res       Date:  2021-06-12       Impact factor: 3.636

9.  The link between vitamin D and COVID-19: distinguishing facts from fiction.

Authors:  P Bergman
Journal:  J Intern Med       Date:  2020-08-05       Impact factor: 13.068

Review 10.  MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19.

Authors:  John P Bilezikian; Daniel Bikle; Martin Hewison; Marise Lazaretti-Castro; Anna Maria Formenti; Aakriti Gupta; Mahesh V Madhavan; Nandini Nair; Varta Babalyan; Nicholas Hutchings; Nicola Napoli; Domenico Accili; Neil Binkley; Donald W Landry; Andrea Giustina
Journal:  Eur J Endocrinol       Date:  2020-11       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.